Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06643299
PHASE2
Probiotic Use for Recovery Enhancement From Long COVID-19
Sponsor: Rush University Medical Center
View on ClinicalTrials.gov
Summary
The goal of this clinical trial is to learn if probiotics can improve symptoms and quality of life in participants with Long COVID.
Official title: PURE-LC - Probiotic Use for Recovery Enhancement From Long COVID
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
180
Start Date
2025-05-13
Completion Date
2026-07
Last Updated
2025-09-03
Healthy Volunteers
No
Conditions
Interventions
DRUG
Probiotic Agent
BlueBiology: Ultimate Care probiotic pill taken once daily for a four-month period.
OTHER
Placebo
Placebo produced to be identical in taste and appearance to the probiotic agent, taken once daily for a four-month period.
Locations (1)
Rush University Medical Center
Chicago, Illinois, United States